GRAY MARY ANN
Insider CIK 1261974 · ACAD Director · SNMX Director · SNCA Director · TLOG Director · GALE Director · KROS Director · RAPT Director · CMPX Director · BCAB Director · JNP Director · SRPT Director · DYAX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KROS Keros Therapeutics, Inc. | A Award deriv | 2026-06-03 | 2026-06-05 | 7,433 | — | $0 | 7,433 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award | 2026-06-03 | 2026-06-05 | 7,142 | — | $0 | 12,392 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | D To issuer deriv | 2026-03-03 | 2026-03-05 | 938 | — | $0 | 0 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | D To issuer deriv | 2026-03-03 | 2026-03-05 | 498 | — | $0 | 0 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | D To issuer deriv | 2026-03-03 | 2026-03-05 | 2,813 | — | $0 | 0 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | D To issuer deriv | 2026-03-03 | 2026-03-05 | 938 | — | $0 | 0 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | D To issuer deriv | 2026-03-03 | 2026-03-05 | 484 | — | $0 | 0 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | D To issuer deriv | 2026-03-03 | 2026-03-05 | 1,063 | — | $0 | 0 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | D To issuer deriv | 2026-03-03 | 2026-03-05 | 560 | — | $0 | 0 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | D To issuer deriv | 2026-03-03 | 2026-03-05 | 1,618 | — | $0 | 0 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | D To issuer deriv | 2026-03-03 | 2026-03-05 | 1,072 | — | $0 | 0 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | D To issuer deriv | 2026-03-03 | 2026-03-05 | 4,561 | — | $0 | 0 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | D To issuer deriv | 2026-03-03 | 2026-03-05 | 7,650 | — | $0 | 0 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | D To issuer deriv | 2026-03-03 | 2026-03-05 | 32,229 | — | $0 | 0 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | D To issuer deriv | 2026-03-03 | 2026-03-05 | 478 | — | $0 | 0 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | U Tender | 2026-03-03 | 2026-03-05 | 4,956 | — | $0 | 0 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award | 2026-01-30 | 2026-02-02 | 4,956 | — | $0 | 4,956 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | A Award deriv | 2026-01-02 | 2026-01-05 | 90,000 | — | $0 | 90,000 | SEC↗ |
| BCAB BioAtla, Inc. | A Award | 2025-06-18 | 2025-06-18 | 23,500 | — | $0 | 77,397 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2025-06-04 | 2025-06-06 | 10,500 | — | $0 | 10,500 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award | 2025-06-04 | 2025-06-06 | 5,250 | — | $0 | 5,250 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2025-05-29 | 2025-06-02 | 257,832 | — | $0 | 257,832 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2025-03-31 | 2025-04-02 | 61,202 | $1.06 | $64.9K | 61,202 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | A Award deriv | 2025-02-11 | 2025-02-13 | 40,000 | — | $0 | 40,000 | SEC↗ |
| BCAB BioAtla, Inc. | A Award | 2024-06-13 | 2024-06-14 | 16,500 | — | $0 | 53,897 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2024-05-30 | 2024-06-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2024-05-22 | 2024-05-23 | 36,490 | — | $0 | 36,490 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2024-03-28 | 2024-04-01 | 8,574 | $7.58 | $65.0K | 8,574 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | A Award deriv | 2024-02-09 | 2024-02-14 | 40,000 | — | $0 | 40,000 | SEC↗ |
| BCAB BioAtla, Inc. | A Award | 2023-12-31 | 2024-01-03 | 5,995 | — | $0 | 37,397 | SEC↗ |
| PALI PALISADE BIO, INC. | A Award deriv | 2023-11-21 | 2023-11-24 | 6,880 | — | $0 | 6,880 | SEC↗ |
| PALI PALISADE BIO, INC. | A Award deriv | 2023-11-21 | 2023-11-24 | 5,820 | — | $0 | 5,820 | SEC↗ |
| BCAB BioAtla, Inc. | A Award | 2023-09-30 | 2023-10-03 | 8,676 | — | $0 | 31,402 | SEC↗ |
| BCAB BioAtla, Inc. | A Award | 2023-06-30 | 2023-07-05 | 4,916 | — | $0 | 22,726 | SEC↗ |
| BCAB BioAtla, Inc. | A Award deriv | 2023-06-14 | 2023-06-15 | 50,000 | — | $0 | 50,000 | SEC↗ |
| PALI PALISADE BIO, INC. | A Award deriv | 2023-06-11 | 2023-06-13 | 5,100 | — | $0 | 5,100 | SEC↗ |
| PALI PALISADE BIO, INC. | A Award deriv | 2023-06-11 | 2023-06-13 | 12,160 | — | $0 | 12,160 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2023-05-24 | 2023-05-25 | 12,940 | — | $0 | 12,940 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2023-03-31 | 2023-04-10 | 4,477 | $14.52 | $65.0K | 4,477 | SEC↗ |
| BCAB BioAtla, Inc. | A Award | 2023-03-31 | 2023-05-15 | 5,503 | — | $0 | 17,810 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | A Award deriv | 2023-02-08 | 2023-02-09 | 40,000 | — | $0 | 40,000 | SEC↗ |
| BCAB BioAtla, Inc. | A Award deriv | 2022-06-16 | 2022-06-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2022-06-01 | 2022-06-03 | 8,293 | — | $0 | 8,293 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2022-05-25 | 2022-05-26 | 8,500 | — | $0 | 8,500 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | A Award deriv | 2022-04-26 | 2022-04-28 | 45,000 | — | $0 | 45,000 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2022-03-31 | 2022-04-04 | 3,868 | $16.80 | $65.0K | 3,868 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award deriv | 2022-03-07 | 2022-03-08 | 5,077 | — | $0 | 5,077 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award | 2022-03-07 | 2022-03-08 | 2,953 | — | $0 | 12,356 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise deriv | 2021-12-10 | 2021-12-14 | 967 | — | $0 | 0 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise | 2021-12-10 | 2021-12-14 | 967 | — | $0 | 9,403 | SEC↗ |
| PALI PALISADE BIO, INC. | A Award deriv | 2021-11-18 | 2022-02-10 | 48,340 | — | $0 | 48,340 | SEC↗ |
| BCAB BioAtla, Inc. | A Award deriv | 2021-06-15 | 2021-06-16 | 12,307 | — | $0 | 12,307 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2021-06-01 | 2021-06-03 | 8,293 | — | $0 | 8,293 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2021-05-28 | 2021-06-24 | 7,500 | — | $0 | 7,500 | SEC↗ |
| SNCA Seneca Biopharma, Inc. | A Award deriv | 2021-04-01 | 2021-04-26 | 6,000 | — | $0 | 6,000 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2021-03-31 | 2021-04-02 | 3,822 | $15.70 | $60.0K | 3,822 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award deriv | 2021-03-03 | 2021-03-05 | 5,518 | — | $0 | 5,518 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award | 2021-03-03 | 2021-03-05 | 2,726 | — | $0 | 8,436 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2020-12-17 | 2020-12-21 | 16,587 | — | $0 | 16,587 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise deriv | 2020-12-10 | 2020-12-10 | 967 | — | $0 | 967 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise | 2020-12-10 | 2020-12-10 | 967 | — | $0 | 5,710 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2020-06-18 | 2020-06-19 | 7,500 | — | $0 | 7,500 | SEC↗ |
| SNCA Seneca Biopharma, Inc. | A Award deriv | 2020-04-03 | 2020-04-07 | 6,000 | — | $0 | 6,000 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2020-03-31 | 2020-04-02 | 3,984 | $15.06 | $60.0K | 3,984 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award deriv | 2020-02-28 | 2020-02-28 | 3,685 | — | $0 | 3,685 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award | 2020-02-28 | 2020-02-28 | 2,075 | — | $0 | 4,743 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise deriv | 2019-12-10 | 2019-12-10 | 967 | — | $0 | 1,934 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise | 2019-12-10 | 2019-12-10 | 967 | — | $0 | 2,668 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2019-12-04 | 2019-12-06 | 22,500 | — | $0 | 22,500 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award deriv | 2019-03-04 | 2019-03-04 | 3,213 | — | $0 | 3,213 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award | 2019-03-04 | 2019-03-04 | 1,633 | — | $0 | 1,701 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award deriv | 2018-12-10 | 2018-12-11 | 5,711 | — | $0 | 5,711 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award deriv | 2018-12-10 | 2018-12-11 | 2,901 | — | $0 | 2,901 | SEC↗ |
| SNMX SENOMYX INC | D To issuer deriv | 2018-11-02 | 2018-11-02 | 20,000 | — | $0 | 0 | SEC↗ |
| SNMX SENOMYX INC | D To issuer deriv | 2018-11-02 | 2018-11-02 | 20,000 | — | $0 | 0 | SEC↗ |
| SNMX SENOMYX INC | U Tender | 2018-11-02 | 2018-11-02 | 10,000 | $1.50 | $15.0K | 0 | SEC↗ |
| JNP JUNIPER PHARMACEUTICALS IN | D To issuer | 2018-08-14 | 2018-08-15 | 16,244 | $11.50 | $186.8K | 0 | SEC↗ |
| SNMX SENOMYX INC | A Award deriv | 2018-05-24 | 2018-05-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| GALE Galena Biopharma, Inc. | A Award | 2017-10-10 | 2017-10-10 | 15,472 | $0.38 | $5.9K | 39,167 | SEC↗ |
| GALE Galena Biopharma, Inc. | A Award | 2017-07-06 | 2017-07-06 | 9,866 | $0.59 | $5.8K | 23,695 | SEC↗ |
| JNP JUNIPER PHARMACEUTICALS IN | A Award | 2017-06-30 | 2017-07-05 | 8,910 | — | $0 | 16,244 | SEC↗ |
| GALE Galena Biopharma, Inc. | A Award deriv | 2017-06-08 | 2017-07-06 | 5,000 | — | $0 | 5,000 | SEC↗ |
| SNMX SENOMYX INC | A Award deriv | 2017-05-11 | 2017-05-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| GALE Galena Biopharma, Inc. | A Award | 2017-04-10 | 2017-04-12 | 8,815 | $0.59 | $5.2K | 13,829 | SEC↗ |
| SNMX SENOMYX INC | P Buy | 2017-03-24 | 2017-03-27 | 10,000 | $1.00 | $10.0K | 10,000 | SEC↗ |
| GALE Galena Biopharma, Inc. | A Award | 2017-01-20 | 2017-01-24 | 2,525 | $1.98 | $5.0K | 5,004 | SEC↗ |
| JNP JUNIPER PHARMACEUTICALS IN | A Award | 2016-08-02 | 2016-08-03 | 6,064 | — | $0 | 7,334 | SEC↗ |
| GALE Galena Biopharma, Inc. | A Award deriv | 2016-07-14 | 2016-07-18 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2016-06-07 | 2016-06-09 | 10,000 | — | $0 | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2016-06-07 | 2016-06-09 | 6,637 | — | $0 | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2016-06-07 | 2016-06-09 | 10,000 | $9.04 | $90.4K | 149,476 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2016-06-07 | 2016-06-09 | 6,637 | $9.04 | $60.0K | 139,476 | SEC↗ |
| SNMX SENOMYX INC | A Award deriv | 2016-05-20 | 2016-05-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| GALE Galena Biopharma, Inc. | A Award deriv | 2016-04-25 | 2016-04-28 | 200,000 | — | $0 | 200,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2016-04-07 | 2016-04-07 | 10,000 | $1.36 | $13.6K | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2016-04-07 | 2016-04-07 | 10,000 | $1.30 | $13.0K | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2016-04-07 | 2016-04-07 | 57,692 | $1.30 | $75.0K | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2016-04-07 | 2016-04-07 | 55,147 | $1.36 | $75.0K | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2016-04-07 | 2016-04-07 | 55,147 | $1.36 | $75.0K | 122,839 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2016-04-07 | 2016-04-07 | 10,000 | $1.36 | $13.6K | 132,839 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2016-04-07 | 2016-04-07 | 10,000 | $1.30 | $13.0K | 10,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2016-04-07 | 2016-04-07 | 57,692 | $1.30 | $75.0K | 67,692 | SEC↗ |
| JNP JUNIPER PHARMACEUTICALS IN | A Award | 2016-04-05 | 2016-04-06 | 1,270 | — | $0 | 1,270 | SEC↗ |
| DYAX DYAX CORP | D To issuer deriv | 2016-01-22 | 2016-01-22 | 16,667 | — | $0 | 0 | SEC↗ |
| DYAX DYAX CORP | D To issuer | 2016-01-22 | 2016-01-22 | 232,440 | — | $0 | 0 | SEC↗ |
| DYAX DYAX CORP | M Exercise deriv | 2016-01-14 | 2016-01-19 | 6,000 | — | $0 | 0 | SEC↗ |
| DYAX DYAX CORP | M Exercise deriv | 2016-01-14 | 2016-01-19 | 75,000 | — | $0 | 0 | SEC↗ |
| DYAX DYAX CORP | M Exercise deriv | 2016-01-14 | 2016-01-19 | 25,000 | — | $0 | 0 | SEC↗ |
| DYAX DYAX CORP | M Exercise deriv | 2016-01-14 | 2016-01-19 | 8,107 | — | $0 | 0 | SEC↗ |
| DYAX DYAX CORP | M Exercise deriv | 2016-01-14 | 2016-01-19 | 75,000 | — | $0 | 0 | SEC↗ |
| DYAX DYAX CORP | M Exercise deriv | 2016-01-14 | 2016-01-19 | 33,333 | — | $0 | 16,667 | SEC↗ |
| DYAX DYAX CORP | M Exercise | 2016-01-14 | 2016-01-19 | 6,000 | $2.97 | $17.8K | 16,000 | SEC↗ |
| DYAX DYAX CORP | M Exercise | 2016-01-14 | 2016-01-19 | 33,333 | $26.23 | $874.3K | 232,440 | SEC↗ |
| DYAX DYAX CORP | M Exercise | 2016-01-14 | 2016-01-19 | 75,000 | $3.82 | $286.5K | 91,000 | SEC↗ |
| DYAX DYAX CORP | M Exercise | 2016-01-14 | 2016-01-19 | 75,000 | $2.09 | $156.8K | 166,000 | SEC↗ |
| DYAX DYAX CORP | M Exercise | 2016-01-14 | 2016-01-19 | 8,107 | $2.06 | $16.7K | 174,107 | SEC↗ |
| DYAX DYAX CORP | M Exercise | 2016-01-14 | 2016-01-19 | 25,000 | $6.17 | $154.3K | 199,107 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2015-06-15 | 2015-06-17 | 12,500 | — | $0 | 12,500 | SEC↗ |
| SNMX SENOMYX INC | A Award deriv | 2015-05-20 | 2015-05-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| DYAX DYAX CORP | A Award deriv | 2015-05-12 | 2015-05-14 | 50,000 | — | $0 | 50,000 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | A Award deriv | 2015-01-28 | 2015-01-30 | 10,000 | $5.25 | $52.5K | 30,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2015-01-13 | 2015-01-15 | 4,250 | — | $0 | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2015-01-13 | 2015-01-15 | 4,250 | $11.00 | $46.8K | 4,250 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2015-01-13 | 2015-01-15 | 4,250 | $35.00 | $148.8K | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2014-12-15 | 2014-12-17 | 6,500 | — | $0 | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2014-12-15 | 2014-12-17 | 4,250 | — | $0 | 4,250 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2014-12-15 | 2014-12-17 | 1,500 | — | $0 | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2014-12-15 | 2014-12-17 | 6,500 | $8.85 | $57.5K | 8,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2014-12-15 | 2014-12-17 | 12,250 | $31.74 | $388.8K | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2014-12-15 | 2014-12-17 | 4,250 | $11.00 | $46.8K | 12,250 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2014-12-15 | 2014-12-17 | 1,500 | $7.67 | $11.5K | 1,500 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | A Award deriv | 2014-11-05 | 2014-11-07 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2014-06-06 | 2014-06-10 | 12,500 | — | $0 | 12,500 | SEC↗ |
| SNMX SENOMYX INC | A Award deriv | 2014-05-29 | 2014-05-30 | 20,000 | — | $0 | 20,000 | SEC↗ |
| DYAX DYAX CORP | A Award deriv | 2014-05-08 | 2014-05-12 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2013-08-26 | 2013-08-28 | 10,000 | — | $0 | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2013-08-26 | 2013-08-28 | 5,000 | — | $0 | 1,500 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2013-08-26 | 2013-08-28 | 5,000 | $20.62 | $103.1K | 10,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2013-08-26 | 2013-08-28 | 5,000 | $7.67 | $38.4K | 5,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2013-08-26 | 2013-08-28 | 10,000 | $8.49 | $84.9K | 15,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2013-08-26 | 2013-08-28 | 10,000 | $20.71 | $207.1K | 0 | SEC↗ |
| SNMX SENOMYX INC | A Award deriv | 2013-06-13 | 2013-06-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2013-06-07 | 2013-06-11 | 12,500 | — | $0 | 12,500 | SEC↗ |
| DYAX DYAX CORP | D To issuer deriv | 2012-06-20 | 2012-06-22 | 18,000 | — | $0 | 0 | SEC↗ |
| DYAX DYAX CORP | A Award deriv | 2012-06-20 | 2012-06-22 | 3,243 | — | $0 | 3,243 | SEC↗ |
| DYAX DYAX CORP | A Award deriv | 2012-06-20 | 2012-06-22 | 4,864 | — | $0 | 4,864 | SEC↗ |
| DYAX DYAX CORP | D To issuer deriv | 2012-06-20 | 2012-06-22 | 27,000 | — | $0 | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2012-06-08 | 2012-06-11 | 55,147 | — | $0 | 55,147 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2012-06-08 | 2012-06-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SNMX SENOMYX INC | A Award deriv | 2012-06-07 | 2012-06-08 | 15,000 | — | $0 | 15,000 | SEC↗ |